tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KRYS Stock Latest News

Krystal Biotech price target raised to $323 from $220 at Chardan
The FlyKrystal Biotech price target raised to $323 from $220 at Chardan
3h ago
KRYS
Buy Rating on Krystal Biotech Driven by Vyjuvek’s Global Momentum and Upside from Enhanced NK and Corneal Abrasion Pipeline
PremiumRatings
Buy Rating on Krystal Biotech Driven by Vyjuvek’s Global Momentum and Upside from Enhanced NK and Corneal Abrasion Pipeline
4h ago
KRYS
Krystal Biotech: Transitioning to Global Growth as De‑Risked HSV‑1 Gene Therapy Platform Advances Toward Pivotal Stages
PremiumRatings
Krystal Biotech: Transitioning to Global Growth as De‑Risked HSV‑1 Gene Therapy Platform Advances Toward Pivotal Stages
4h ago
KRYS
Krystal Biotech: Strong Vyjuvek Performance, De‑Risked Gene Therapy Pipeline, and International Expansion Underscore Buy Rating and $318 Target
PremiumRatings
Krystal Biotech: Strong Vyjuvek Performance, De‑Risked Gene Therapy Pipeline, and International Expansion Underscore Buy Rating and $318 Target
4h ago
KRYS
Krystal Biotech price target raised to $371 from $336 at Citi
PremiumThe Fly
Krystal Biotech price target raised to $371 from $336 at Citi
5h ago
KRYS
Krystal Biotech Earnings Call Highlights Profitable Growth
PremiumCompany AnnouncementsKrystal Biotech Earnings Call Highlights Profitable Growth
15h ago
KRYS
Krystal Biotech: Strong Vyjuvek Momentum, Robust Balance Sheet, and Late-Stage Pipeline Upside Support Buy Rating
Premium
Ratings
Krystal Biotech: Strong Vyjuvek Momentum, Robust Balance Sheet, and Late-Stage Pipeline Upside Support Buy Rating
17h ago
KRYS
Krystal Biotech price target raised to $371 from $310 at Jefferies
Premium
The Fly
Krystal Biotech price target raised to $371 from $310 at Jefferies
21h ago
KRYS
Krystal Biotech sees FY26 non-GAAP R&D, SG&A expense $175M-$195M
PremiumThe Fly
Krystal Biotech sees FY26 non-GAAP R&D, SG&A expense $175M-$195M
1d ago
KRYS
Krystal Biotech reports Q4 EPS $1.70, consensus $1.61
PremiumThe Fly
Krystal Biotech reports Q4 EPS $1.70, consensus $1.61
1d ago
KRYS
Krystal Biotech, Inc. (KRYS) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Krystal Biotech, Inc. (KRYS) Q4 Earnings Cheat Sheet
3d ago
KRYS
Krystal Biotech granted RMAT designation for KB707 in NSCLC
PremiumThe Fly
Krystal Biotech granted RMAT designation for KB707 in NSCLC
9d ago
KRYS
Krystal Biotech price target raised to $327 from $206 at Goldman Sachs
PremiumThe FlyKrystal Biotech price target raised to $327 from $206 at Goldman Sachs
19d ago
KRYS
Krystal Biotech price target raised to $338 from $288 at Clear Street
Premium
The Fly
Krystal Biotech price target raised to $338 from $288 at Clear Street
23d ago
KRYS
Krystal Biotech price target raised to $318 from $288 at BofA
Premium
The Fly
Krystal Biotech price target raised to $318 from $288 at BofA
27d ago
KRYS
Krystal Biotech outlines rare disease growth strategy update
PremiumCompany Announcements
Krystal Biotech outlines rare disease growth strategy update
1M ago
8K
KRYS
Krystal Biotech price target raised to $336 from $320 at Citi
PremiumThe Fly
Krystal Biotech price target raised to $336 from $320 at Citi
1M ago
KRYS
Krystal Biotech price target raised to $306 from $202 at TD Cowen
PremiumThe Fly
Krystal Biotech price target raised to $306 from $202 at TD Cowen
1M ago
KRYS
Krystal Biotech price target raised to $306 from $202 at TD Cowen
PremiumThe Fly
Krystal Biotech price target raised to $306 from $202 at TD Cowen
1M ago
KRYS
Krystal Biotech price target raised to $288 from $272 at BofA
PremiumThe FlyKrystal Biotech price target raised to $288 from $272 at BofA
1M ago
KRYS
Krystal Biotech price target raised to $320 from $309 at Citi
Premium
The Fly
Krystal Biotech price target raised to $320 from $309 at Citi
1M ago
KRYS
Krystal Biotech price target raised to $288 from $217 at Clear Street
Premium
The Fly
Krystal Biotech price target raised to $288 from $217 at Clear Street
1M ago
KRYS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >